TY - JOUR
T1 - Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display
AU - Saleh, Marwah A.
AU - Ishii, Ken
AU - Yamagami, Jun
AU - Shirakata, Yuji
AU - Hashimoto, Koji
AU - Amagai, Masayuki
N1 - Funding Information:
We thank Dr Aimee Payne (University of Pennsylvania) for providing the scFv-positive control from a PV patient, Dr Tsuyoshi Hata for valuable advice regarding the dissociation assay, and Drs Bungo Ohyama and Takashi Hashimoto for sharing the Dsg3/Dsg2 domain-swapped molecules. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Health and Labour Sciences Research Grants for Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan.
PY - 2012/4
Y1 - 2012/4
N2 - Paraneoplastic pemphigus (PNP) is an autoimmune blistering disease associated with lymphoproliferative neoplasms and characterized by antibodies against plakins and desmoglein 3 (Dsg3). Anti-Dsg3 antibodies have a primary role in blister formation in PNP. In this study, we used phage display to clone monoclonal anti-Dsg3 antibodies from a PNP patient to further characterize their pathogenicity. We isolated 20 unique Dsg3-reactive mAbs, which we classified into four groups according to the heavy-chain complementarity-determining region 3 (CDR3) region. Genetic analyses demonstrated that three antibody groups used the VH1-46 gene (18 clones) and one group used the VH1-02 gene (2 clones). The results of an in vitro keratinocyte dissociation assay and a human skin organ culture injection assay showed that three antibodies displayed pathogenic activity in blister formation with different potencies. Epitope mapping using domain-swapped Dsg3/Dsg2 showed that these pathogenic mAbs bound Ca2+ -dependent conformational epitopes in the middle portion of the extracellular region of Dsg3 (EC2 and EC3 domains), in contrast to most previously characterized pathogenic pemphigus vulgaris antibodies, which bound to the EC1 domain of Dsg3. These mAbs reflect the unique polyclonal nature of anti-Dsg3 antibodies in PNP and represent an important tool for detailing the pathophysiological mechanisms of blister formation in PNP.
AB - Paraneoplastic pemphigus (PNP) is an autoimmune blistering disease associated with lymphoproliferative neoplasms and characterized by antibodies against plakins and desmoglein 3 (Dsg3). Anti-Dsg3 antibodies have a primary role in blister formation in PNP. In this study, we used phage display to clone monoclonal anti-Dsg3 antibodies from a PNP patient to further characterize their pathogenicity. We isolated 20 unique Dsg3-reactive mAbs, which we classified into four groups according to the heavy-chain complementarity-determining region 3 (CDR3) region. Genetic analyses demonstrated that three antibody groups used the VH1-46 gene (18 clones) and one group used the VH1-02 gene (2 clones). The results of an in vitro keratinocyte dissociation assay and a human skin organ culture injection assay showed that three antibodies displayed pathogenic activity in blister formation with different potencies. Epitope mapping using domain-swapped Dsg3/Dsg2 showed that these pathogenic mAbs bound Ca2+ -dependent conformational epitopes in the middle portion of the extracellular region of Dsg3 (EC2 and EC3 domains), in contrast to most previously characterized pathogenic pemphigus vulgaris antibodies, which bound to the EC1 domain of Dsg3. These mAbs reflect the unique polyclonal nature of anti-Dsg3 antibodies in PNP and represent an important tool for detailing the pathophysiological mechanisms of blister formation in PNP.
UR - http://www.scopus.com/inward/record.url?scp=84858285073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858285073&partnerID=8YFLogxK
U2 - 10.1038/jid.2011.449
DO - 10.1038/jid.2011.449
M3 - Article
C2 - 22277944
AN - SCOPUS:84858285073
SN - 0022-202X
VL - 132
SP - 1141
EP - 1148
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 4
ER -